{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:19:08Z","timestamp":1790302748289,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/maj.0000000000000511","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T11:39:51Z","timestamp":1434541191000},"page":"250-256","source":"Crossref","is-referenced-by-count":98,"title":["Mechanisms of Cachexia in Chronic Disease States"],"prefix":"10.1016","volume":"350","author":[{"given":"Tadashi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Delafontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0000000000000511_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: pathophysiology and clinical relevance","volume":"83","author":"Morley","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1097\/MAJ.0000000000000511_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","article-title":"Tumors secreting human TNF\/cachectin induce cachexia in mice","volume":"50","author":"Oliff","year":"1987","journal-title":"Cell"},{"key":"10.1097\/MAJ.0000000000000511_bb0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.04-2364com","article-title":"TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1\/MAFbx in skeletal muscle","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J"},{"key":"10.1097\/MAJ.0000000000000511_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0303-7207(98)00105-1","article-title":"Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice","volume":"142","author":"Llovera","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1097\/MAJ.0000000000000511_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF01262570","article-title":"Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients","volume":"5","author":"Maltoni","year":"1997","journal-title":"Support Care Cancer"},{"key":"10.1097\/MAJ.0000000000000511_bb0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1097\/MAJ.0000000000000511_bb0040","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/bjc.1996.294","article-title":"The relationship between weight loss and interleukin 6 in non-small-cell lung cancer","volume":"73","author":"Scott","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1097\/MAJ.0000000000000511_bb0045","first-page":"1091","article-title":"Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival","volume":"21","author":"Moses","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1097\/MAJ.0000000000000511_bb0050","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1097\/MAJ.0000000000000511_bb0055","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert Opin Biol"},{"key":"10.1097\/MAJ.0000000000000511_bb0060","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1097\/MAJ.0000000000000511_bb0065","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1371\/journal.pgen.0030079","article-title":"A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs","volume":"3","author":"Mosher","year":"2007","journal-title":"Plos Genet"},{"key":"10.1097\/MAJ.0000000000000511_bb0070","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1097\/MAJ.0000000000000511_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2044-5040-2-3","article-title":"TAK-1\/p38\/nNF\u03baB signaling inhibits myoblast differentiation by increasing levels of Activin A","volume":"2","author":"Trendelenburg","year":"2012","journal-title":"Skeletal Muscle"},{"key":"10.1097\/MAJ.0000000000000511_bb0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1097\/MAJ.0000000000000511_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1097\/MAJ.0000000000000511_bb0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0735-1097(01)01385-7","article-title":"Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone","volume":"38","author":"Anker","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/MAJ.0000000000000511_bb0095","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","article-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","volume":"21","author":"Suskin","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1097\/MAJ.0000000000000511_bb0100","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1152\/ajpendo.00456.2007","article-title":"Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase","volume":"294","author":"Wei","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1097\/MAJ.0000000000000511_bb0105","doi-asserted-by":"crossref","first-page":"e10070","DOI":"10.1371\/journal.pone.0010070","article-title":"Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms","volume":"5","author":"Csibi","year":"2010","journal-title":"PLoS One"},{"key":"10.1097\/MAJ.0000000000000511_bb0110","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","article-title":"Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study","volume":"361","author":"Anker","year":"2003","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0000000000000511_bb0115","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/j.1532-5415.2005.53568.x","article-title":"Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension","volume":"53","author":"Schellenbaum","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1097\/MAJ.0000000000000511_bb0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1532-5415.2004.52265.x","article-title":"Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study","volume":"52","author":"Di Bari","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1097\/MAJ.0000000000000511_bb0125","first-page":"541","article-title":"Lisinopril administration improves insulin action in aged patients with hypertension","volume":"9","author":"Paolisso","year":"1995","journal-title":"J Hum Hypertens"},{"key":"10.1097\/MAJ.0000000000000511_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13539-012-0072-8","article-title":"Evidence for an effect of ACE inhibitors on cancer cachexia","volume":"3","author":"Schanze","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1097\/MAJ.0000000000000511_bb0135","first-page":"1","article-title":"New muscle for ARB strategy. SciBX: acience-business exchange","volume":"4","author":"Osherovich","year":"2011","journal-title":"Nat Publishing Group"},{"key":"10.1097\/MAJ.0000000000000511_bb0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J Intern Med"},{"key":"10.1097\/MAJ.0000000000000511_bb0145","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI118698","article-title":"Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism","volume":"97","author":"Brink","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1097\/MAJ.0000000000000511_bb0150","first-page":"631","article-title":"Mechanisms of skeletal muscle atrophy","volume":"18","author":"Ventadour","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1097\/MAJ.0000000000000511_bb0155","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1097\/MAJ.0000000000000511_bb0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI22324","article-title":"Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting","volume":"115","author":"Song","year":"2005","journal-title":"J Clin Invest Am Soc Clin Invest"},{"key":"10.1097\/MAJ.0000000000000511_bb0165","doi-asserted-by":"crossref","first-page":"H1565","DOI":"10.1152\/ajpheart.00146.2010","article-title":"IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression","volume":"298","author":"Yoshida","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1097\/MAJ.0000000000000511_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbrc.2011.04.122","article-title":"Angiotensin II induced catabolic effect and muscle atrophy are redox dependent","volume":"409","author":"Semprun-Prieto","year":"2011","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1097\/MAJ.0000000000000511_bb0175","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/endo.142.4.8082","article-title":"Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I","volume":"142","author":"Brink","year":"2001","journal-title":"Endocrinology"},{"key":"10.1097\/MAJ.0000000000000511_bb0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1152\/physiol.00041.2007","article-title":"Signaling in muscle atrophy and hypertrophy","volume":"23","author":"Sandri","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"10.1097\/MAJ.0000000000000511_bb0185","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo","volume":"3","author":"Bodine","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1097\/MAJ.0000000000000511_bb0190","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1097\/MAJ.0000000000000511_bb0195","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1101\/gad.1089403","article-title":"Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2","volume":"17","author":"Peng","year":"2003","journal-title":"Genes Dev"},{"key":"10.1097\/MAJ.0000000000000511_bb0200","doi-asserted-by":"crossref","first-page":"9213","DOI":"10.1073\/pnas.142166599","article-title":"A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification","volume":"99","author":"Pallafacchina","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1097\/MAJ.0000000000000511_bb0205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/84839","article-title":"Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle","volume":"27","author":"Musaro","year":"2001","journal-title":"Nat Genet"},{"key":"10.1097\/MAJ.0000000000000511_bb0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MCO.0b013e328338b9a6","article-title":"MAFbx\/Atrogin-1 expression is a poor index of muscle proteolysis","volume":"13","author":"Attaix","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1097\/MAJ.0000000000000511_bb0215","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","article-title":"The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle","volume":"6","author":"Clarke","year":"2007","journal-title":"Cell Metab"},{"key":"10.1097\/MAJ.0000000000000511_bb0220","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200901052","article-title":"During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation","volume":"185","author":"Cohen","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1097\/MAJ.0000000000000511_bb0225","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1074\/jbc.M411346200","article-title":"Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase","volume":"280","author":"Tintignac","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1097\/MAJ.0000000000000511_bb0230","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/emboj.2008.52","article-title":"The initiation factor eIF3-f is a major target for Atrogin1\/MAFbx function in skeletal muscle atrophy","volume":"27","author":"Lagirand-Cantaloube","year":"2008","journal-title":"EMBO J"},{"key":"10.1097\/MAJ.0000000000000511_bb0235","doi-asserted-by":"crossref","first-page":"C548","DOI":"10.1152\/ajpcell.00502.2008","article-title":"FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner","volume":"297","author":"McLoughlin","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1097\/MAJ.0000000000000511_bb0240","doi-asserted-by":"crossref","first-page":"C38","DOI":"10.1152\/ajpcell.00315.2009","article-title":"FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70","volume":"298","author":"Senf","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1097\/MAJ.0000000000000511_bb0245","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1097\/MAJ.0000000000000511_bb0250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2005.02.007","article-title":"Angiotensin II directly inhibits protein synthesis in murine myotubes","volume":"231","author":"Russell","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1097\/MAJ.0000000000000511_bb0255","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2008060628","article-title":"IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting","volume":"20","author":"Zhang","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0000000000000511_bb0260","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ Res"},{"key":"10.1097\/MAJ.0000000000000511_bb0265","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.mcna.2009.02.014","article-title":"The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress","volume":"93","author":"Manrique","year":"2009","journal-title":"Med Clin North Am"},{"key":"10.1097\/MAJ.0000000000000511_bb0270","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.HYP.0000240347.51386.ea","article-title":"Reactive oxygen species impair sympathetic vasoregulation in skeletal muscle in angiotensin II-dependent hypertension","volume":"48","author":"Zhao","year":"2006","journal-title":"Hypertension"},{"key":"10.1097\/MAJ.0000000000000511_bb0275","doi-asserted-by":"crossref","first-page":"35137","DOI":"10.1074\/jbc.M601320200","article-title":"Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells","volume":"281","author":"Wei","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1097\/MAJ.0000000000000511_bb0280","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1152\/ajpendo.00609.2011","article-title":"Mitochondrial signaling contributes to disuse muscle atrophy","volume":"303","author":"Powers","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1097\/MAJ.0000000000000511_bb0285","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/ajpregu.00767.2006","article-title":"Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production","volume":"293","author":"Muller","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1097\/MAJ.0000000000000511_bb0290","doi-asserted-by":"crossref","first-page":"e15354","DOI":"10.1371\/journal.pone.0015354","article-title":"Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse","volume":"5","author":"Whitehead","year":"2010","journal-title":"PLoS One"},{"key":"10.1097\/MAJ.0000000000000511_bb0295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.ATV.20.3.645","article-title":"Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress","volume":"20","author":"Pueyo","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/MAJ.0000000000000511_bb0300","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0006-291X(92)91308-D","article-title":"Changes in skin angiotensin II receptors in rats during wound healing","volume":"187","author":"Kimura","year":"1992","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1097\/MAJ.0000000000000511_bb0305","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/HYPERTENSIONAHA.111.174839","article-title":"Angiotensin II upregulates protein phosphatase 2C\u03b1 and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting","volume":"58","author":"Tabony","year":"2011","journal-title":"Hypertension"},{"key":"10.1097\/MAJ.0000000000000511_bb0310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J"},{"key":"10.1097\/MAJ.0000000000000511_bb0315","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2007.05.006","article-title":"S6 kinase deletion suppresses muscle growth Adaptations to nutrient availability by activating AMP kinase","volume":"5","author":"Aguilar","year":"2007","journal-title":"Cell Metab"},{"key":"10.1097\/MAJ.0000000000000511_bb0320","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1271\/bbb.70057","article-title":"AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes","volume":"71","author":"Nakashima","year":"2007","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1097\/MAJ.0000000000000511_bb0325","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2044-5040-4-20","article-title":"Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function","volume":"4","author":"Tabony","year":"2014","journal-title":"Skeletal Muscle"},{"key":"10.1097\/MAJ.0000000000000511_bb0330","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1097\/MAJ.0000000000000511_bb0335","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","article-title":"Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care\u2013correlations with food intake, metabolism, exercise capacity, and hormones","volume":"103","author":"Fouladiun","year":"2005","journal-title":"Cancer"},{"key":"10.1097\/MAJ.0000000000000511_bb0340","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(02)03676-4","article-title":"Effect of central angiotensin II on body weight gain in young rats","volume":"959","author":"Porter","year":"2003","journal-title":"Brain Res"},{"key":"10.1097\/MAJ.0000000000000511_bb0345","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1152\/ajpregu.00537.2003","article-title":"Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats","volume":"287","author":"Porter","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"10.1097\/MAJ.0000000000000511_bb0350","doi-asserted-by":"crossref","first-page":"E1081","DOI":"10.1152\/ajpendo.00307.2011","article-title":"Central angiotensin-II has catabolic action at white and brown adipose tissue","volume":"301","author":"de Kloet","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1097\/MAJ.0000000000000511_bb0355","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/en.2011-1764","article-title":"Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus","volume":"153","author":"Yoshida","year":"2012","journal-title":"Endocrinology"},{"key":"10.1097\/MAJ.0000000000000511_bb0360","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/frne.1997.0155","article-title":"Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review","volume":"18","author":"Lenkei","year":"1997","journal-title":"Front Neuroendocrinol"},{"key":"10.1097\/MAJ.0000000000000511_bb0365","series-title":"Regenerating the heart","first-page":"173","article-title":"Skeletal muscle stem cells in the spotlight: the satellite cell","author":"Yablonka-Reuveni","year":"2011"},{"key":"10.1097\/MAJ.0000000000000511_bb0370","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1152\/japplphysiol.00778.2005","article-title":"Myofiber degeneration\/regeneration is induced in the cachectic ApcMin\/+ mouse","volume":"99","author":"Mehl","year":"2005","journal-title":"J Appl Physiol (1985)"},{"key":"10.1097\/MAJ.0000000000000511_bb0375","doi-asserted-by":"crossref","first-page":"e13604","DOI":"10.1371\/journal.pone.0013604","article-title":"Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition","volume":"5","author":"Penna","year":"2010","journal-title":"PLoS One"},{"key":"10.1097\/MAJ.0000000000000511_bb0380","first-page":"1663","article-title":"Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation","volume":"26","author":"Costelli","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1097\/MAJ.0000000000000511_bb0385","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1126\/science.1087573","article-title":"Notch-mediated restoration of regenerative potential to aged muscle","volume":"302","author":"Conboy","year":"2003","journal-title":"Science"},{"key":"10.1097\/MAJ.0000000000000511_bb0390","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature11438","article-title":"The aged niche disrupts muscle stem cell quiescence","volume":"490","author":"Chakkalakal","year":"2012","journal-title":"Nature"},{"key":"10.1097\/MAJ.0000000000000511_bb0395","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1534-5807(02)00254-X","article-title":"The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis","volume":"3","author":"Conboy","year":"2002","journal-title":"Dev Cell."},{"key":"10.1097\/MAJ.0000000000000511_bb0400","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature07034","article-title":"Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells","volume":"454","author":"Carlson","year":"2008","journal-title":"Nature"},{"key":"10.1097\/MAJ.0000000000000511_bb0405","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nature03260","article-title":"Rejuvenation of aged progenitor cells by exposure to a young systemic environment","volume":"433","author":"Conboy","year":"2005","journal-title":"Nature"},{"key":"10.1097\/MAJ.0000000000000511_bb0410","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.1251152","article-title":"Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle","volume":"344","author":"Sinha","year":"2014","journal-title":"Science"},{"key":"10.1097\/MAJ.0000000000000511_bb0415","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drudis.2007.10.008","article-title":"Novel approaches to the treatment of cachexia","volume":"13","author":"Argil\u00e9s","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1097\/MAJ.0000000000000511_bb0420","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00508-009-1194-7","article-title":"Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review","volume":"121","author":"Doehner","year":"2009","journal-title":"Wien Klin Wochenschr"},{"key":"10.1097\/MAJ.0000000000000511_bb0425","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: a systematic overview","volume":"121","author":"Haehling von","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1097\/MAJ.0000000000000511_bb0430","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1097\/MAJ.0000000000000511_bb0435","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat Med"},{"key":"10.1097\/MAJ.0000000000000511_bb0440","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0363546508315470","article-title":"Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle","volume":"36","author":"Bedair","year":"2008","journal-title":"Am J Sports Med"},{"key":"10.1097\/MAJ.0000000000000511_bb0445","doi-asserted-by":"crossref","first-page":"82ra37","DOI":"10.1126\/scitranslmed.3002227","article-title":"Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia","volume":"3","author":"Burks","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1097\/MAJ.0000000000000511_bb0450","doi-asserted-by":"crossref","first-page":"e15212","DOI":"10.1371\/journal.pone.0015212","article-title":"Regulation of muscle satellite cell activation and chemotaxis by angiotensin II","volume":"5","author":"Johnston","year":"2010","journal-title":"PLoS One"},{"key":"10.1097\/MAJ.0000000000000511_bb0455","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1152\/ajpregu.00007.2012","article-title":"Disruption of muscle renin-angiotensin system in AT1a-\/- mice enhances muscle function despite reducing muscle mass but compromises repair after injury","volume":"303","author":"Murphy","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1097\/MAJ.0000000000000511_bb0460","doi-asserted-by":"crossref","first-page":"23823","DOI":"10.1074\/jbc.M112.449074","article-title":"Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration","volume":"288","author":"Yoshida","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1097\/MAJ.0000000000000511_bb0465","doi-asserted-by":"crossref","first-page":"26239","DOI":"10.1074\/jbc.M114.585521","article-title":"Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration","volume":"289","author":"Yoshida","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1097\/MAJ.0000000000000511_bb0470","doi-asserted-by":"crossref","first-page":"PE16","DOI":"10.1126\/stke.2003.181.pe16","article-title":"Angiotensin type 2 receptor (AT2R): a challenging twin","volume":"2003","author":"Berk","year":"2003","journal-title":"Sci STKE"},{"key":"10.1097\/MAJ.0000000000000511_bb0475","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/hmg\/ddt514","article-title":"Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF- signalling","volume":"23","author":"Acuna","year":"2014","journal-title":"Hum Mol Genet"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915412947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915412947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T19:00:55Z","timestamp":1652468455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915412947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0002962915412947"],"URL":"https:\/\/doi.org\/10.1097\/maj.0000000000000511","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}